These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
668 related items for PubMed ID: 18945448
21. Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis. Viiri LE, Viiri KM, Ilveskoski E, Huhtala H, Mäki M, Tienari PJ, Perola M, Lehtimäki T, Karhunen PJ. Circ Cardiovasc Genet; 2008 Dec; 1(2):107-16. PubMed ID: 20031552 [Abstract] [Full Text] [Related]
22. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program. Vossen CY, Hoffmann MM, Hahmann H, Wüsten B, Rothenbacher D, Brenner H. Clin Pharmacol Ther; 2008 Aug; 84(2):222-7. PubMed ID: 18388879 [Abstract] [Full Text] [Related]
23. [The relationship of apolipoprotein H G1025C (Try316Ser) polymorphism with stroke and its effect on plasma lipid levels in Changsha Hans]. Xia J, Yang Q, Yang Q, Xu H, Zhang L. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):114-8. PubMed ID: 12673579 [Abstract] [Full Text] [Related]
29. [Plasma level of Lp(a) in patients with myocardial infarct is not controlled by the apolipoprotein E gene polymorphism]. Hubácek JA, Stávek P, Pit'ha J, Skodová Z, Poledne R. Cas Lek Cesk; 2001 Jun 07; 140(11):332-4. PubMed ID: 11431852 [Abstract] [Full Text] [Related]
31. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins. Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R. Ren Fail; 2006 Jun 07; 28(7):567-71. PubMed ID: 17050239 [Abstract] [Full Text] [Related]
34. Lipid metabolism in cognitive decline and dementia. Panza F, D'Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA, Capurso A, Solfrizzi V. Brain Res Rev; 2006 Aug 07; 51(2):275-92. PubMed ID: 16410024 [Abstract] [Full Text] [Related]
35. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects. Moreno JA, Pérez-Jiménez F, Moreno-Luna R, Pérez-Martínez P, Fuentes-Jiménez F, Marín C, Portugal H, Lairon D, López-Miranda J. Br J Nutr; 2009 Jun 07; 101(12):1745-52. PubMed ID: 19025720 [Abstract] [Full Text] [Related]
36. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients. Bednarska-Makaruk M, Rodo M, Graban A, Lojkowska W, Bochyńska A, Ryglewicz D, Wehr H. J Neurol Sci; 2009 Aug 15; 283(1-2):137-8. PubMed ID: 19303604 [Abstract] [Full Text] [Related]
37. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia. Akanji AO, Ohaeri JU, Al-Shammri SN, Fatania HR. Neuropsychobiology; 2009 Aug 15; 60(2):67-72. PubMed ID: 19752580 [Abstract] [Full Text] [Related]
38. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, Irving WL, Trent HCV Study Group. Hepatology; 2002 Aug 15; 36(2):456-63. PubMed ID: 12143056 [Abstract] [Full Text] [Related]
39. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study. Do HQ, Nazih H, Luc G, Arveiler D, Ferrières J, Evans A, Amouyel P, Cambien F, Ducimetière P, Bard JM. Metabolism; 2009 Mar 15; 58(3):283-9. PubMed ID: 19217440 [Abstract] [Full Text] [Related]
40. The effect of genetic determinants of low density lipoprotein levels on lipoprotein (a). Hegele RA, Sutherland S, Robertson M, Wu L, Emi M, Hopkins PN, Williams RR, Lalouel JM. Clin Invest Med; 1991 Apr 15; 14(2):146-52. PubMed ID: 1829402 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]